Older adults who received two doses of the shingles vaccine had a 33% lower rate of developing vascular dementia over nearly three years compared to those who did not receive the vaccine.

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.